Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?

Adverse drug reactions (ADRs) account for a large proportion of hospitalizations among adults and are more common in multimorbid patients, worsening clinical outcomes and burdening healthcare resources. Over the past decade, pharmacogenomics has been developed as a practical tool for optimizing trea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of clinical pharmacology Jg. 91; H. 2; S. 270 - 282
Hauptverfasser:	Peruzzi, Elena, Roncato, Rossana, De Mattia, Elena, Bignucolo, Alessia, Swen, Jesse J., Guchelaar, Henk‐Jan, Toffoli, Giuseppe, Cecchin, Erika
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley and Sons Inc 01.02.2025
Schlagworte:	adverse drug reactions Cost-Effectiveness Analysis Drug-Related Side Effects and Adverse Reactions - economics Drug-Related Side Effects and Adverse Reactions - genetics Drug-Related Side Effects and Adverse Reactions - prevention & control Humans Pharmacogenetics - economics Pharmacogenetics - methods Pharmacogenomic Testing - economics Pharmacogenomic Testing - methods pharmacogenomics Precision Medicine - economics Precision Medicine - methods PREPARE trial pre‐emptive Randomized Controlled Trials as Topic Themed Issue Review pre‐emptive adverse drug reactions pharmacogenomics PREPARE trial
ISSN:	0306-5251, 1365-2125, 1365-2125
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!